Limited role of mutation in guiding immunotherapy in advanced non-small-cell lung cancer.
- Resource Type
- journal article
- Authors
- Li, Hong-Shuai; Liu, Cheng-Ming; Wang, Yan
- Source
- Future Oncology; Jul2022, Vol. 18 Issue 19, p2433-2443, 11p
- Subject
- TREATMENT of lung tumors
LUNG cancer
PROTEINS
GENETIC mutation
HETEROCYCLIC compounds
LUNG tumors
ORGANIC compounds
IMMUNOMODULATORS
RESEARCH funding
IMMUNOTHERAPY
- Language
- ISSN
- 14796694
Copyright of Future Oncology is the property of Future Medicine Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)